V2X, Inc. (then Vectrus, Inc.) — Form 10-Q Summary
Reporting period: Quarter ended July 3, 2020; comparative quarter ended June 28, 2019. The filing was submitted under the name Vectrus, Inc. and reports its business as one segment providing services primarily to the U.S. Government, especially the Department of Defense.
Financial performance
| Metric | Q2 2020 | Q2 2019 | First half 2020 | First half 2019 |
|---|---|---|---|---|
| Revenue | $336.1 million | $331.6 million | $687.8 million | $657.5 million |
| Operating income | $2.4 million | $11.2 million | $14.9 million | $21.6 million |
| Operating margin | 0.7% | 3.4% | 2.2% | 3.3% |
| Net income | $1.1 million | $7.6 million | $9.8 million | $14.7 million |
| Diluted EPS | $0.09 | $0.66 | $0.83 | $1.28 |
| Operating cash flow | Not provided by quarter | Not provided by quarter | $34.4 million | $15.5 million |
- Margins and earnings: Q2 revenue grew 1.3%, but cost of revenue rose 3.7% and SG&A rose 9.9%; operating income fell 78.3%. For the first half, revenue increased 4.6%, while operating income declined 30.9% and net income declined 33.4%.
- Cash flow and liquidity: First-half investing cash outflow was $2.2 million and financing cash outflow was $4.8 million. Cash was $62.7 million at July 3, 2020, including $12.3 million held abroad. The company reported $117.6 million of available revolver capacity and said liquidity should be sufficient for at least 12 months. First-half operating cash flow included $13.3 million from CARES Act tax deferrals.
- Debt: Short-term debt was $7.5 million and long-term debt, net, was $59.2 million. Net debt was $4.8 million. The company drew and repaid $115 million of revolver borrowings during the first half to address potential liquidity risk; it reported no revolver borrowings at quarter-end. It was in compliance with its debt covenants.
- Other metrics: Receivables were $260.3 million, including $196.2 million of unbilled contract assets; approximately $8.1 million of unbilled receivables may not be collected within 12 months. Remaining performance obligations were $1.02 billion, with approximately 62% expected to be recognized in 2020 and 38% in 2021. Total backlog was $3.8 billion, including $904 million funded.
Material changes and drivers
- Q2 revenue growth reflected $10.3 million from the Advantor acquisition, partly offset by lower activity on existing contracts. Management estimated COVID-19 reduced Q2 revenue by $22.3 million and EPS by $0.14; first-half impacts were estimated at $24.6 million and $0.16, respectively.
- Management attributed the sharp Q2 operating-income decline mainly to lower income from Middle East programs ($6.6 million) and European programs ($2.1 million), as well as a European contract adjustment. Cost of revenue increased as a share of sales to 92.8% from 90.6%.
- First-half revenue growth included $21.5 million from Advantor and $8.8 million from expansion of existing contracts. Firm-fixed-price revenue increased 26.4% year over year for the first half, while cost-plus and cost-reimbursable revenue decreased 1.8%.
- First-half contract-estimate catch-up adjustments reduced operating income by $3.8 million, compared with a $0.8 million benefit in the prior-year period. Q2 adjustments reduced income by $1.5 million, versus a $1.9 million benefit a year earlier.
Outlook, risks, contingencies, and unusual items
- Management gave no numerical earnings or revenue guidance. It expected to fund operations and planned investment with operating cash flow, cash, and credit facilities, while noting future financing availability could be affected by markets and economic conditions.
- Backlog increased by $1.051 billion during the first half. Subsequent to quarter-end, the company received a $529.1 million K-BOSSS contract modification on July 24, with $248.0 million obligated at award. On August 5, a prime contractor notified the company it intended not to exercise remaining options on a subcontract, which management said would reduce backlog by approximately $398.5 million.
- COVID-19 caused base-access restrictions and supplier delays. Management warned that the pandemic’s duration and effects on employees, contract execution, supply chains, funding, and cost recovery remained uncertain and could materially affect future results and cash flows.
- Government contract funding, termination rights, audits, cost disallowances, and award protests are ongoing risks. One LOGCAP V award appeal remained pending. The company recorded $13.5 million for legal proceedings and government-contract claims; it did not expect the identified matters to materially harm its financial condition, results, or cash flow.
- The company disclosed an immaterial restatement of prior-period balances arising from errors in contract cost estimates and customer overbilling. The cumulative reduction to retained earnings at December 31, 2019 was $2.5 million; reported 2019 net income was reduced by $1.5 million for the year. Management concluded the errors were not material to prior periods.
- COVID-related goodwill impairment assessment resulted in no impairment charge. A foreign tax matter resolved in Q2 contributed to the lower first-half effective tax rate of 17.6%, versus 21.4%.
Important facts for investors to verify
- Whether COVID-related operating disruptions, contract cost increases, and recovery of those costs persist beyond the period covered by the filing.
- The status and financial impact of the pending LOGCAP V appeal, the K-BOSSS modification, and the subcontract options expected not to be exercised.
- Whether reported backlog converts to funded work and revenue on expected schedules, given government funding, contract options, and termination rights.
- The sustainability of operating cash flow, particularly the contribution from CARES Act tax deferrals and working-capital timing.
- Developments in government audits, claims, uncertain tax positions, and the prior-period accounting corrections.